liver neuroendocrine carcinoma
ORPHA: 100085
Overview
extremely rare, aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with liver neuroendocrine carcinoma, sourced from HPO and Orphanet clinical annotations.
BronchoconstrictionNeoplasm of the liverNeuroendocrine neoplasmAscitesWeight lossDiarrheaNauseaAnorexiaDyspneaHepatomegalyEpisodic abdominal painChronic noninfectious lymphadenopathyElevated circulating hepatic transaminase concentrationAbdominal distentionChronic fatigueHepatic cystsRight ventricular failurePalpitationsHepatic encephalopathyIncreased serum serotoninFacial telangiectasiaErythematous plaqueHeart murmurNight sweatsCarcinoid tumorPtosisIntermittent jaundiceNeoplasm of the nervous systemBiliary tract obstructionIntrahepatic cholestasis with episodic jaundiceReduced visual acuityElevated alkaline phosphatase of hepatic originAbnormal brain FDG positron emission tomographyElevated gamma-glutamyltransferase levelNeoplasm of the eyeNeoplasm of the lung
Classification & Codes
Orphanet Code
ORPHA:100085liver neuroendocrine carcinoma
| Orphanet | ORPHA:100085 |
| Treatments | 0 drug(s) |
| Symptoms on record | 36 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO